Abstract
The enzyme-linked immunosorbent assay (ELISA) was used to determine levels of specific IgG antibodies against measles, rubella, vaccinia, corona (OC43) and mumps viruses in cerebrospinal fluid (CSF) and serum of 18 patients with clinically definite multiple sclerosis (MS), 8 patients with optic neuritis (ON), 27 patients with other neurological disease (OND), and 88 control subjects without central nervous system disease. Serum antibody levels were not significantly different between the four groups. Differences in the frequency and levels of CSF antibodies between the four groups were observed. Control patients had serumCSF antibody ratios from 2.0 to 3.0 (log) with an average of 2.5 corresponding to a 320-fold difference between serum and CSF antibody levels. MS patients had ratios from 1.1 to 2.1 with an average of 1.6. The average was 2.0 for the ON patients. The average for the OND patients was similar to the controls. The altered serumCSF ratios for several viruses within an individual patient was similar. These results suggest that nonspecific immunostimulation is responsible for the increased levels of CSF virus antibodies.
Footnotes
This work was supported in part by the Kroc Foundation, Santa Ynez, California and by the Sigrid Juselius Foundation, Helsinki, Finland.
References
- Frick E., Scheid-Seydel L. Untersuchungen mit J131-markierten gamma-globulin zur Frage der Abstammung der Liquoreiweisskörper. Klin. Wschr. 1958;36:857–863. doi: 10.1007/BF01485232. [DOI] [PubMed] [Google Scholar]
- Haire M. Significance of virus antibodies. Brit. med. Bull. 1977;33:40–44. doi: 10.1093/oxfordjournals.bmb.a071394. [DOI] [PubMed] [Google Scholar]
- Iivanainen M., Leinikki P., Taskinen E., Shekarchi I., Madden D., Sever J. CSF oligoclonal bands, immunoglobulins, and viral antibodies in progressive myoclonus epilepsy. Arch. Neurol. (Chic.) 1981;38:206–208. doi: 10.1001/archneur.1981.00510040032003. [DOI] [PubMed] [Google Scholar]
- Leinikki P., Pässilä S. Solid phase antibody assay by means of enzyme conjugated to anti-immunoglobulin. J. clin. Path. 1976;29:1116–1120. doi: 10.1136/jcp.29.12.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leinikki P., Pässilä S. Quantitative, semiautomated enzyme-linked immunosorbent assay for viral antibodies. J. infect. Dis. 1977;136:294–300. doi: 10.1093/infdis/136.supplement_2.s294. [DOI] [PubMed] [Google Scholar]
- Leinikki P.O., Shekarchi I., Dorsett P., Sever J. Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples. J. clin. Microbiol. 1978;8:419–423. doi: 10.1128/jcm.8.4.419-423.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leinikki P.O., Shekarchi I., Tzan N., Madden D., Sever J. Vol. 160. 1979. Evaluation of enzyme-linked immunosorbent assay (ELISA) for mumps virus antibodies; pp. 363–367. (Proc. Soc. exp. Biol. (N.Y.)). [DOI] [PubMed] [Google Scholar]
- Link H. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Acta neurol. scand. 1967;43(Suppl. 28):1–136. [PubMed] [Google Scholar]
- Norrby E. Viral antibodies in multiple sclerosis. Progr. Med. Virol. 1978;24:1–39. [PubMed] [Google Scholar]
- Schumacher G.A., Beeke G., Kibler R.F., Kurland L.T., Kurtzke J.F., McDowell F., Nagler B., Sibley W.A., Tourtellotte W.W., Willman T.L. Problems of experimental trials of therapy in multiple sclerosis — Report of the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann. N.Y. Acad. Sci. 1965;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
- Tourtellotte W.W., Parker J.A. Correlation between immunoglobulin G in cerebrospinal fluid and brain. Science. 1966;154:1044–1046. doi: 10.1126/science.154.3752.1044. [DOI] [PubMed] [Google Scholar]